Methotrexate
NDC 63323-123, METHOTREXATE SODIUM, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-123
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRA-ARTERIAL, INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040263
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM25 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-123-10 | 63323012310 | 1 VIAL in 1 CARTON (63323-123-10) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b585f621-f6c9-4735-ab61-bd1b401f3df0Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-123NADAC price for package 63323012310
GET /v1/drugs/nadac/63323012310
Use it
Look up 63323-123 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.